1. PREPARED FOR

APPLICANT

ORIGINAL EQUIPMENT MANUFACTURER
OWN BRAND LABELER

Manufacturer Name and Full Address
(To be printed in the CE Certificate)

CONTACT PERSON

APPLICANT
REPRESENTATIVE / CONSULTANT



2. PREPARED BY
Alsstr. 97, 41063 Mönchengladbach, Germany
1st Floor,221,BSK 3 stage,Bengaluru-85, India
58, Peregrine Road, Essex, England, IG6 3SZ, UK
336 Sutro Forest NW, Concord, NC 28027, USA
R2202, 609 Truong Dinh, Hoang Mai, Hanoi, VN
NAME
CONTACT NUMBER
EMAIL
DATE
PROPOSAL NUMBER I3C-IVD--REV:
PROPOSAL VALIDITY
3. EXECUTIVE SUMMARY

This business proposal was submitted with complete confidence in the device, IVDR regulation, and Notified Body requirements. Our scope covers guidance, team consultation, technical documentation, performance evaluation (Limited), Clinical Performance, risk analysis, biological evaluation, labeling, and Notified Body review comment responses.

Even if client staff are not directly involved in the technical documentation, it is essential that they communicate with us and provide accurate information, documentation, and records about the facility and product.

The client team can keep track of the work at any stage throughout Technical Document preparation and NB review since all customer-provided documents and records will be transmitted in real-time into the cloud. We guarantee that all supplied information will be kept confidential. We have obtained ISO 27701:2016 certification for data security.

4. DEVICE INFORMATION

1. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

2. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

3. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

4. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

5. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

6. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

7. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

8. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

9. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

10. Device Name

    Device Class & GMDN Code

    

    Models & Variants

    Pricing

5. PROJECT FEE AND PAYMENT TERMS

IVDR Technical Documentation Fee for the above listed device(s)

(In Words)

With NB Coordination: 40:30:20:10

40% advance, 30% before NB submission, 20% initial NB response, 10% receipt of draft certificate

Without (Phase 10) NB Coordination: 40:30:30

40% advance, 30% after RMF and PER, 30% before technical file handover

All payments to I3CGLOBAL must be made using the tax invoices generated according to the schedules above.

6. STATEMENT OF WORK

PHASE

ACTIVITY

SCOPE OF I3CGLOBAL

SCOPE OF MANUFACTURER

PHASE 1

Legal Verification

  • Review and approval
  • Confirmation of scope
  • Review and approval
  • Confirmation of production site address
  • Law of Land Certificate
  • Company Registration Certificate
  • Incorporation Certificate.
  • Review and approval
  • Confirmation of critical outsourcing locations
  • Review and approval
  • Quality Management Certificate

Device Verification

  • Review and approval
  • Device Models confirmation
  • Guidance, Review and Approval
  • Generic name
  • Guidance, Review and Approval
  • GMDN Code
  • Review and approval
  • Trade Name / Brand Name
  • Guidance, Review & Approval
  • What is to be detected and/or measured
  • Guidance, Review & Approval
  • In-vitro medical device function
  • Guidance, Review & Approval
  • Specific disorder, condition, or risk factor
  • Guidance, Review & Approval
  • Process - automatic or not
  • Guidance, Review & Approval
  • Qualitative, semi-quantitative or quantitative
  • Guidance, Review & Approval
  • Type of specimen(s)
  • Guidance, Review & Approval
  • Testing population
  • Guidance, Review & Approval
  • Intended users
  • Guidance, Review & Approval
  • Companion diagnostics
  • Guidance, Review & Approval
  • Target population
  • Guidance, Review & Approval
  • Associated medicinal product(s)
  • Guidance, Review & Approval
  • Principle of operation
  • Guidance, Review & Approval
  • In vitro diagnostic medical device rationale
  • Guidance, Review & Approval
  • Device classification and justification
  • Guidance, Review & Approval
  • Key components description
  • Guidance, Review & Approval
  • Description of the specimen collection

PHASE 2

Confirmation of IVDR requirements and compliance issues

  • Identification of regulations

 

  • Harmonized Standards

 

  • Non-Harmonized standards

 

  • Device specific standards

 

  • Other applicable regulations if any

 

  • Declaration of Conformity

 

  • Documentation of additional declarations

 

PHASE 3

Design Controls
(Active, Non-Active Devices)
In line with ISO 13485

  • Design and development procedure.

 

  • Review and Feedback
  • Development Plan
  • Review and Feedback
  • Design & development inputs
  • Review and Feedback
  • Design & development outputs
  • Review and Feedback
  • Design Verification
  • Review and Feedback
  • Design Validation
  • Review and Feedback
  • Design Approvals
  • Review and Feedback
  • Formulation / Drawings/ Specifications
  • Review and Feedback
  • Bill of Material
  • Review and Feedback
  • Design & development Review

Design Controls
(Software)
In line with ISO 62304

  • Review and Feedback
  • Development Plan
  • Review and Feedback
  • Requirements Analysis
  • Review and Feedback
  • Architectural Design
  • Review and Feedback
  • Detailed Design
  • Review and Feedback
  • Unit Implementation
  • Review and Feedback
  • Unit Verification
  • Review and Feedback
  • Integration & Integration Testing
  • Review and Feedback
  • System Testing
  • Review and Feedback
  • Software Configuration Management
  • Review and Feedback
  • Software Risk Management Process
  • Review and Feedback
  • The code and code reviews
  • Review and Feedback
  • Software validation and release.

PHASE 4

Risk Analysis & Usability

  • Development of Procedures and Templates
  • Conduct of risk Analysis
  • Team support and suggestions
  • Guidance
  • Risk Mitigation
  • Risk Benefit analysis
  • Risk Management File documentation
  • Review and approval
  • Usability engineering procedure and template
  • Team support and suggestions
  • Review and approval
  • Usability engineering report

PHASE 5

Product verification and validation

  • Analytical performance characteristics
  • Appoint 3rd party agencies if required) approval
  • Guidance, Review & Approval
  • Accuracy of measurement
  • Guidance, Review & Approval
  • Analytical sensitivity
  • Guidance, Review & Approval
  • Analytical specificity
  • Guidance, Review & Approval
  • Metrological traceability of calibrator and control material values
  • Guidance, Review & Approval
  • Measuring range of the assay
  • Scientific Validity Report conclusion
  • Data generation and approval
  • The analytical performance report
  • Data generation and approval

PHASE 6

Production controls

  • Guidance, review, and approval

  • Process Flow Chart
  • Guidance
  • Critical Process identification
  • Review and approval
  • Critical Process validation protocol and reports
  • Review and approval
  • Sterilization Process Validation Protocol
  • Review and approval
  • Sterilization Process Validation Report
  • Guidance
  • Environmental Controls
  • Review and approval
  • Cleanroom Validation protocol and Records
  • Review and approval
  • Bioburden protocol and Records

PHASE 7

Device Labelling

  • Guidance, review, and approval
  • Primary / Secondary Labels including embossing’s submit as per guidance

Information For Use /
User manual

  • Guidance, review, and approval
  • Develop and submit IFU / User manual as per guidance

Device Storage

  • Review, and approval
  • Confirmation of storage time and condition

Lifetime / Shelf-Life

  • Guidance, review, and approval
  • Lifetime / Shelf-Life Protocol and Reports

Packaging Controls
(Active, Non-Active Devices)

  • Guidance, review, and approval
  • Method of Packing
  • Packing Validation and Reports
  • Transport Validation and Reports

PHASE 8

Quality Control

  • Review and approval
  • Specification of Finished Device
  • Review and approval
  • Specification of Critical Raw Materials / Components
  • Review and approval
  • Quality Plan / Control Plan
  • Guidance, review, and approval
  • Certificate of Analysis (COA)
  • Guidance, review, and approval
  • Batch Release
  • Review and approval
  • Performance Testing
  • Review and approval
  • Electrical Safety Testing

PHASE 9

Clinical performance and clinical evidence

  • Clinical Performance Study Procedure

 

  • Clinical Performance Study plan

 

  • Clinical Performance Study Plan Report
  • Organize the activities based on guidance

Post Market Surveillance and Vigilance Reporting

  • Develops or modifies the PMS procedure, if required
  • Analysis based of collected PMS data based on the reactive and proactive sources selected by the manufacturer.
  • Support PMS planning
  • PMS period confirmation
  • Supports in selecting the sources from our PMS Plan provided by us.
  • Guidance on Vigilance and CAPA if required.
  • Decision on whether PMCF study needs to be conducted based on the feedback and risk classification
  • Preparation of PMS report if Class I or PSUR if class IIa and above 
  • Vigilance Control Procedure as per MEDDEV 2.12-1 rev 8
  • Extent necessary support by following PMS plan scheduled for the period.
  • Collect PMS data based on the PMS sources chosen
  • Organize Customer Feedback
  • Organize Sales History and Sales volume data
  • Organize User Feedback in the drafted and provided.
  • Follow Vigilance and CAPAs if any required.
  • Review and approve PMS plan, other evidence and PMSR/PSUR

Post Market Performance Follow-up

  • Prepares procedure for PMPF, if required.
    • Analysis & and derive conclusion.
    • Follow PMPF study based on Consultants Inputs
    • Review and approve PMPF plan and PMPF Evaluation Report

PHASE 10

Notified Body Submission, Review and Site Audit and Issue of Certificate

  • Support identification of Notified Body

 

  • Application

 

  • Technical Documentation Submission

 

  • Answering to Notified Body Review comments
  • Team support and suggestions
  • Review draft Certificate
  • Review draft Certificate

 

  • Accept the electronic and hard copies of the CE Certificate
7. PROJECT TIMELINE

According to our observations of other manufacturers throughout the world, technical documentation typically takes three to four months. Implementation of EN ISO 13485:2016, internal and external testing, validations, and gathering clinical data, among other things, may all be completed in the same amount of time.

The typical Notified Body technical documentation review, onsite audit, and certificate issuance procedure for Class B and Class C devices takes nine months to a year, and longer for Class D devices.

8. GENERAL TERMS OF BUSINESS

8.1 NON DISCLOSURE AGREEMENT
All Confidential information statements and information of any kind given by the applicant will be treated with the highest secrecy and confidence. Without the applicant's specific written approval, we will not divulge such confidential information to any third party. Directors, officers, employees, and consultants will use the confidential information disclosed pursuant to this agreement solely for the purpose and will ensure that such persons are bound by confidentiality obligations that limit the disclosure and use of the confidential information as contemplated by this agreement.
8.2 PROPOSAL MODIFICATION
No modification, termination, or attempted waiver of this agreement, or any component of it, shall be valid unless it is in writing and signed by the party seeking to enforce it.
8.3 GUARANTEE ON PROJECT OUTCOME
We are unable to promise CE Certification. To successfully complete the project, we will continually rely on our technical proficiency and experience in earlier project completion. The manufacturers' onsite QMS implementation, the quality of the materials, finished product, and performance evaluation are aspects that affect CE certification.
8.4 NOTIFIED BODY REVIEW FEE
The Notified Body conducts technical documentation reviews a maximum of two to three times. Additional reviews will incur fees in accordance with the signed agreement's terms with the manufacturer and notified body. We cannot guarantee that the technical file will be approved after two reviews. As consultants, our goal is to complete each project successfully with the fewest feasible expenditures and time delays.
8.5 NON-AVAILABILITY OF TECHNICAL INFORMATION WITH MANUFACTURER
The manufacturer (OEL/OBL/PLM) must organize documents/records/device technical information at our consultants' request. All submitted items must always be assessed by our team, who will formally notify you if they are unacceptable. The manufacturer must take the necessary steps to fix it. Any delays incurred are not our fault.
8.6 SURPRISE EXPENSES AFTER PROJECT START
Based on the device characteristics, raw materials utilized, inadequate data, sales feedback, clinical feedback, and device-specific international and harmonized standards, extra costs may arise after project start-up based on our thorough investigation.
8.7 DOCUMENT SECURITY AND PROJECT CONTACTS
The technical file is being handled, prepared, reviewed, and protected at the central depository located in Bangalore, India. The project-related first-line point of contact is the team lead. The guidance and technical documentation will be taken up by technical consultants. If you feel there is an unresolved issue or a matter that requires additional attention, you should contact the project head who has signed clause 10 of this proposal.
8.8 REFUND
If a discrepancy in clause 4 is detected after the project begins, payments will not be refunded.
8.9 CONSULTANT(S) VISIT TO MANUFACTURER LOCATION.
Most of the time, a consultant doesn't need to go to the manufacturer's facility. If any unresolved concerns, we may send a member to your location to address them. Based on the availability our experts travel from Chicago, Bangalore, Düsseldorf, and London. The manufacturer is required to make travel and accommodation arrangements.
8.10 PROJECT DELAY PENALTY
We are committed to finishing tasks on schedule. The CE Certification procedure is divided into three steps. They are (1) Technical Documentation (2) Technical Documentation Review by Notified Body (3) Onsite Audit. The technical documentation must be sent to the notified body within five months, and this is the joint duty of I3CGLOBAL and the manufacturer. Therefore, whoever is to blame for a delay that lasts more than six months must pay $50 a day in compensation


9. PROPOSAL REVIEW
Name : Soio George
Designation : Project Head
Email : sg@i3cglobal.com
Date :

I read, reviewed, and confirmed that the information is accurate to the best of my knowledge. I appreciate the opportunity to present our proposal to you, and I look forward to working with you.

I accept

 

10. PROPOSAL APPROVAL

Name :
Designation :
Email :
Date :

I acknowledge that I have read and understand the working pattern, scope of both parties, risk involved, and potential variations in project assumptions and timetables, and I now accept them. I3CGLOBAL is now requested to submit an advance payment invoice so that the project can begin as soon as possible.

I accept